CT in progress: two #Dermalfillers First-In-Class FDA Pivotal Phase III Trials @galderma

#Dermatology News: Galderma Delivers Innovation In Dermal Fillers With The Launch Of Two FirstInClass FDA Pivot… https://t.co/cuXJLV0dZc

— Dermatology News (@Dermatology_bio) February 26, 2016